Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study.
Clinical trial NCT03163381 · UNKNOWN
Trial details
- NCT number
- NCT03163381
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-11
- Primary completion
- 2017-10-11
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.